iCMLf Conversations: Biological Highlights of the ESH-iCMLf 26th Annual John Goldman Conference

(33:38)

iCMLf Conversations: Clinical Highlights of the ESH-iCMLf 26th Annual John Goldman Conference

(22:40)

iCMLf Conversations: Highlights of the 25th John Goldman Conference - Clinical Overview

(19:25)

iCMLf Conversations: Management of Advanced Phases of CML

(37:53)

ICMLF Conversations - Meet the Expert Q\u0026A Session; Prof Jane Apperley \u0026 Prof Giuseppe Saglio

(53:45)

iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Biological overview

(16:54)

iCMLf Conversation: CML Highlights of EHA 2022 - Biological and clinical overview

(1:5:16)

iCMLf Conversation: CML Highlights of ASH 2022 - Biological overview

(42:37)

iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Clinical overview incl. Q...

(31:15)

iCMLf Conversation: Treatment of CML patients after failure of 2 TKIs

(46:54)

iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview

(30:55)

iCMLf Conversation: CML Highlights of EHA 2023; Clinical and Biological Overview

(52:49)

iCMLf Conversation: Highlights of 25th John Goldman Conference - Biological Overview \u0026 Q\u0026A Session

(34:48)

iCMLf Conversation in FRENCH: Update on CML and COVID-19 management

(26:25)

iCMLf Conversation CML and COVID management in Spanish.mp4

(56:6)

Community Conversations

(1:2:47)

ASH 2022 iCMLf Forum Introduction

(41:1econd)